Home / News / India News / Article /
Corbevax Covid-19 vaccine receives EUA approval for 12-18 age group
Updated On: 21 February, 2022 07:03 PM IST | New Delhi | IANS
The Drugs Controller General of India (DCGI) had already approved Corbevax for restricted use in emergency situation among adults on December 28, 2019. BE received the approval for restricted use in an emergency situation in adolescents aged 12 to less than 18 years based on interim results (of the ongoing phase 2/3 clinical study)
Listen to this article :
Representative image
Vaccine manufacturer Biological E Ltd announced that its Covid-19 vaccine Corbevax has received emergency use authorisation (EUA) from India`s drug regulator for the 12 to 18-year age group.
According to the Hyderabad-based firm, Corbevax is India`s first indigenously developed Receptor Binding Domain (RBD) protein sub-unit vaccine against Covid-19.
Trending Stories
Latest Photos
Latest Videos
Latest Web Stories
ADVERTISEMENT
Mid-Day Fast
ADVERTISEMENT
ADVERTISEMENT